1型与2型糖尿病的心血管结局
本文综述1型和2型糖尿病心血管疾病(CVD)与早逝风险;2型糖尿病患病率上升对全球健康影响巨大;管理关键在于绝对风险和终生风险,终生控糖、控脂、控压及不吸烟是预防关键。
要点
- 1型糖尿病仅占全部病例少数,但早发使患者长期暴露于高血糖。
- 2型糖尿病患病率上升抵消了许多国家CVD死亡率下降的进展。
- 管理核心是绝对风险和终生风险,需终生控糖、控脂、控压和不吸烟。
核心结论
- 1型和2型糖尿病的主要长期结局均为CVD和早逝,但哪种类型风险最高尚有争议且研究不广泛。
- 管理糖尿病最重要的是绝对风险和终生风险,终生控糖、控脂、控压和不吸烟是预防关键,健康生活方式和药物治疗按需实施。
研究设计与样本
- 综述,检索范围未在摘要中报告。
主要发现
- 1型糖尿病近期估计占全球所有病例约2%,但早发使许多人长期带病生存。
- 糖尿病患者相比非糖尿病的超额风险很大程度上取决于其他因素,如LDL胆固醇升高、高血压和吸烟等一般心血管危险因素,以及HbA1c、微量和大白蛋白尿等糖尿病特异因素。
- 部分 contributory 因素可改变,而年龄、性别和糖尿病类型不可改变。
- 危险因素控制良好的老年2型糖尿病患者CVD风险可达到与一般人群相似的水平,而年轻1型糖尿病患者大多无法达到相似风险水平,可能因长期累积暴露于高血糖。
- 尽管有报告1型和2型糖尿病患者CVD发生率下降,但两型糖尿病患病率上升导致全球心脏代谢疾病人数持续增加,抵消了许多国家取得的进展。
临床怎么用
- 终生努力实现血糖控制、血脂和高血压控制以及不吸烟是预防关键,健康生活方式和药物治疗按需实施。
局限性
- 1型和2型糖尿病个体之间CVD风险的比较充满困难,且高度依赖其他伴随因素,其中一些可改变而另一些不可改变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Diabetes is one of the most prevalent cardiometabolic disorders on the planet. Type 1 diabetes accounts for only a minority of all cases (recently estimated to be ~2% globally); however, since this is a disorder with an early onset, many people live with type 1 diabetes for a long time. CVD and premature death are the main long-term outcomes for both types of diabetes; however, the type of diabetes that carries the highest risk of these outcomes is a controversial topic and has not been widely studied. Because of the association between diabetes and CVD, the rise in type 2 diabetes prevalence over the past decades has huge effects on global health. The excess risk in people with diabetes compared with those without depends, to a large extent, on the presence of other factors, such as general cardiovascular risk factors (e.g. elevated LDL-cholesterol, hypertension and smoking) and also factors that are more specific to diabetes (e.g. HbA1c, and micro- and macroalbuminuria). Some contributory factors are modifiable, while others are not, such as age, sex and type of diabetes. Older people with type 2 diabetes who have risk factors that are under control can achieve levels of CVD risk that are similar to that of the general population, while younger individuals with type 1 diabetes are mostly unable to achieve similar levels of risk, probably because of long and cumulative exposure to raised blood glucose levels. Despite reports of declining rates of CVD among people with type 1 and type 2 diabetes, rising rates of both types of diabetes lead to a continuing rise in the number of people with cardiometabolic disorders worldwide, offsetting the progress made in many countries. Comparison between individuals with type 1 and type 2 diabetes with respect to risk of CVD is fraught with difficulties and highly dependent on other, concomitant factors, some of which are modifiable and others not. Nonetheless, as a whole, what matters most in determining the management of diabetes is absolute risk and lifetime risk. Life-long efforts to achieve glycaemic control, control of lipids and hypertension, and not smoking are key to prevention, with a healthy lifestyle and pharmacological therapy to be implemented as needed.
引用
- Rosengren A, Dikaiou P. Cardiovascular outcomes in type 1 and type 2 diabetes. Diabetologia. 2023. PMID: 36640192. doi:10.1007/s00125-022-05857-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。